Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-05-27 00:21 | 2021-05-24 | SELB | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.72 | 1,900,000 | $7,059,830 | 19,154,427 | +11.0% |
| 2021-05-27 02:02 | 2021-05-24 | MORF | N/A | SPRINGER TIMOTHY A | Director, 10% owner | Other | BUY | $46.28 | 130,000 | $6,015,997 | 837,314 | +18.4% |
| 2021-05-25 18:01 | 2021-05-21 | FET | FORUM ENERGY TECHNOLOGIES, INC. | CARRIG JOHN A | Director | Oil & Gas Field Machinery & Equipment | BUY | $22.28 | 50,000 | $1,114,000 | 50,900 | +5,555.6% |
| 2021-05-26 03:31 | 2021-05-21 | RAIN | N/A | BVF PARTNERS L P/IL | Director, 10% owner, Other | Other | BUY | $15.94 | 123,347 | $1,966,336 | 112,482 | +100.0% |
| 2021-05-25 23:27 | 2021-05-21 | SELB | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.19 | 2,773,479 | $8,847,398 | 17,254,427 | +19.2% |
| 2021-05-26 02:03 | 2021-05-21 | MORF | N/A | SPRINGER TIMOTHY A | Director, 10% owner | Other | BUY | $45.50 | 232,295 | $10,569,423 | 707,314 | +48.9% |
| 2021-05-24 23:09 | 2021-05-20 | MCAEU | N/A | Mountain Crest Holdings III LLC | 10% owner | Other | BUY | $10.00 | 110,000 | $1,100,000 | 1,541,500 | +7.7% |
| 2021-05-24 23:09 | 2021-05-20 | MCAEU | N/A | Liu Suying | Director, Officer, 10% owner - CEO and CFO | Other | BUY | $10.00 | 110,000 | $1,100,000 | 1,541,500 | +7.7% |
| 2021-05-24 21:42 | 2021-05-20 | PFSI | PennyMac Financial Services, Inc. | MFN Partners, LP | Director | Mortgage Bankers & Loan Correspondents | BUY | $61.46 | 103,586 | $6,366,168 | 2,584,066 | +4.2% |
| 2021-05-24 15:42 | 2021-05-21 | PTON | PELOTON INTERACTIVE, INC. | TCV X Cycle, L.P. | Other | Sporting & Athletic Goods, NEC | BUY | $101.01 | 29,218 | $2,951,415 | 4,878 | +100.0% |
| 2021-05-24 15:39 | 2021-05-19 | PTON | PELOTON INTERACTIVE, INC. | TCV X Cycle, L.P. | Other | Sporting & Athletic Goods, NEC | BUY | $99.19 | 89,264 | $8,854,409 | 3,675 | +100.0% |
| 2021-05-24 22:16 | 2021-05-20 | PFSI | PennyMac Financial Services, Inc. | NANJI FARHAD | Director | Mortgage Bankers & Loan Correspondents | BUY | $61.46 | 103,586 | $6,366,168 | 2,584,066 | +4.2% |
| 2021-05-24 22:42 | 2021-05-20 | CWGL | Crimson Wine Group, Ltd | Cumming John D. | Director, 10% owner | Beverages | BUY | $8.65 | 359,646 | $3,110,938 | 939,193 | +62.1% |
| 2021-05-24 22:19 | 2021-05-20 | CWGL | Crimson Wine Group, Ltd | STEINBERG JOSEPH S | Director, 10% owner | Beverages | BUY | $8.65 | 359,646 | $3,110,938 | 986,929 | +57.3% |
| 2021-05-24 13:13 | 2021-05-21 | FRG | N/A | KAHN BRIAN RANDALL | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $36.00 | 1,000,000 | $36,000,000 | 1,342,788 | +291.7% |
| 2021-05-25 00:47 | 2021-05-20 | CRCT | Cricut, Inc. | Abdiel Capital Management, LLC | 10% owner | Special Industry Machinery, NEC | BUY | $28.07 | 253,674 | $7,120,173 | 2,096,091 | +13.8% |
| 2021-05-24 15:43 | 2021-05-21 | PTON | PELOTON INTERACTIVE, INC. | TCV IX Cycle, L.P. | 10% owner, Other | Sporting & Athletic Goods, NEC | BUY | $101.01 | 69,778 | $7,048,527 | 15,443 | +100.0% |
| 2021-05-24 15:41 | 2021-05-19 | PTON | PELOTON INTERACTIVE, INC. | TCV IX Cycle, L.P. | 10% owner, Other | Sporting & Athletic Goods, NEC | BUY | $99.19 | 213,177 | $21,145,773 | 11,635 | +100.0% |
| 2021-05-24 23:24 | 2021-05-24 | CLNN | Clene Inc. | MATLIN DAVID J | Director | Pharmaceutical Preparations | BUY | $9.63 | 207,684 | $1,999,997 | 1,378,897 | +17.7% |
| 2021-05-24 20:04 | 2021-05-18 | T | AT&T INC. | LUCZO STEPHEN J | Director | Telephone Communications (No Radiotelephone) | BUY | $29.80 | 100,000 | $2,980,270 | 300,000 | +50.0% |
| 2021-05-24 23:02 | 2021-05-20 | MVEN | Arena Group Holdings Inc. | B. Riley Financial, Inc. | 10% owner | Cable & Other Pay Television Services | BUY | $0.70 | 2,857,143 | $2,000,000 | 63,025,483 | +4.7% |
| 2021-05-25 01:49 | 2021-05-20 | ARYA | Nautilus Biotechnology, Inc. | PERCEPTIVE ADVISORS LLC | Director | Laboratory Analytical Instruments | BUY | $10.05 | 159,925 | $1,607,246 | 159,925 | +100.0% |
| 2021-05-24 21:27 | 2021-05-12 | SAFE | N/A | ISTAR INC. | 10% owner | Other | BUY | $68.61 | 127,623 | $8,756,380 | 34,993,591 | +0.4% |
| 2021-05-22 00:15 | 2021-05-17 | MICT | N/A | Mercer Darren | Director, Officer - CEO | Other | BUY | $1.41 | 6,000,000 | $8,460,000 | 6,000,000 | +100.0% |
| 2021-05-22 01:44 | 2021-05-19 | RRD | N/A | Chatham Asset Management, LLC | 10% owner | Other | BUY | $5.47 | 1,423,085 | $7,787,833 | 8,899,990 | +19.0% |
| 2021-05-22 03:19 | 2021-05-19 | GDRX | GoodRx Holdings, Inc. | Silver Lake Group, L.L.C. | Director, 10% owner | Services-Computer Processing & Data Preparation | BUY | $30.78 | 393,811 | $12,120,006 | 3,467,872 | +12.8% |
| 2021-05-21 21:06 | 2021-05-19 | ESPR | Esperion Therapeutics, Inc. | BIOTECH TARGET N V | 10% owner | Pharmaceutical Preparations | BUY | $20.37 | 200,000 | $4,073,960 | 4,377,964 | +4.8% |
| 2021-05-20 22:18 | 2021-05-18 | PFSI | PennyMac Financial Services, Inc. | MFN Partners, LP | Director | Mortgage Bankers & Loan Correspondents | BUY | $60.88 | 120,960 | $7,363,634 | 2,480,480 | +5.1% |
| 2021-05-20 22:27 | 2021-05-18 | PFSI | PennyMac Financial Services, Inc. | NANJI FARHAD | Director | Mortgage Bankers & Loan Correspondents | BUY | $60.88 | 120,960 | $7,363,634 | 2,480,480 | +5.1% |
| 2021-05-20 21:39 | 2021-05-03 | ETTX | N/A | Innoviva, Inc. | 10% owner | Other | BUY | $2.00 | 3,731,025 | $7,462,050 | 3,731,025 | +100.0% |
| 2021-05-21 02:18 | 2021-05-18 | RAIN | N/A | BVF PARTNERS L P/IL | Director, Other | Other | BUY | $16.59 | 208,465 | $3,457,726 | 104,761 | +100.0% |
| 2021-05-20 04:04 | 2021-05-17 | APP | AppLovin Corporation Class A Common Stock | Foroughi Arash Adam | Director, Officer, 10% owner - CEO & Chairperson | Services-Computer Programming, Data Processing, Etc. | BUY | $61.72 | 100,000 | $6,172,000 | 100,000 | +100.0% |
| 2021-05-19 16:42 | 2021-05-18 | AGR | N/A | Iberdrola, S.A. | 10% owner | Other | BUY | $51.40 | 63,424,125 | $3,260,000,025 | 315,659,357 | +25.1% |
| 2021-05-20 04:05 | 2021-05-17 | APP | AppLovin Corporation Class A Common Stock | Chen Herald Y | Director, Officer - President & CFO | Services-Computer Programming, Data Processing, Etc. | BUY | $61.01 | 25,000 | $1,525,208 | 25,000 | +100.0% |
| 2021-05-20 01:07 | 2021-05-17 | CUTR | N/A | PLANTS J DANIEL | Director | Other | BUY | $29.50 | 664,828 | $19,612,426 | 1,210,224 | +121.9% |
| 2021-05-18 22:27 | 2021-05-14 | PFSI | PennyMac Financial Services, Inc. | MFN Partners, LP | Director | Mortgage Bankers & Loan Correspondents | BUY | $60.44 | 182,798 | $11,048,914 | 2,359,520 | +8.4% |
| 2021-05-19 03:17 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Katabi Maha | Director, 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 727,272 | $7,999,992 | 2,914,776 | +33.2% |
| 2021-05-18 22:36 | 2021-05-14 | PFSI | PennyMac Financial Services, Inc. | NANJI FARHAD | Director | Mortgage Bankers & Loan Correspondents | BUY | $60.44 | 182,798 | $11,048,914 | 2,359,520 | +8.4% |
| 2021-05-18 19:03 | 2021-05-11 | KMF | N/A | UNITED OF OMAHA LIFE INSURANCE CO | 10% owner | Other | BUY | $25.00 | 100,000 | $2,500,000 | 2,500,000 | +4.2% |
| 2021-05-19 03:20 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Longitude Capital Partners IV, LLC | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 909,090 | $9,999,990 | 3,096,594 | +41.6% |
| 2021-05-19 01:00 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 772,727 | $8,499,997 | 2,960,231 | +35.3% |
| 2021-05-19 03:14 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 909,090 | $9,999,990 | 3,096,594 | +41.6% |
| 2021-05-19 03:10 | 2021-05-17 | VERA | Vera Therapeutics, Inc. | EMSTER KURT VON | Director | Pharmaceutical Preparations | BUY | $11.02 | 790,555 | $8,714,683 | 2,960,231 | +36.4% |
| 2021-05-19 03:23 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 727,272 | $7,999,992 | 2,914,776 | +33.2% |
| 2021-05-18 18:28 | 2021-05-14 | NIHK | Video River Networks, Inc. | Video River Networks, Inc. | Director, Officer, 10% owner - President and CEO | Real Estate | BUY | $30,800.36 | 550,000 | $16,940,198,000 | 31,511,230 | +1.8% |
| 2021-05-18 04:17 | 2021-05-13 | XM | N/A | Silver Lake Group, L.L.C. | Director, 10% owner | Other | BUY | $31.01 | 217,590 | $6,748,206 | 16,101 | +100.0% |
| 2021-05-18 03:39 | 2021-04-23 | RAIN | N/A | BVF PARTNERS L P/IL | Director, Other | Other | BUY | $16.86 | 1,133,309 | $19,103,396 | 88,226 | +100.0% |
| 2021-05-17 16:22 | 2021-05-13 | ELOX | N/A | PAREKH RAJESH B | Director | Other | BUY | $1.35 | 2,466,666 | $3,329,999 | 4,827,129 | +104.5% |
| 2021-05-17 14:03 | 2021-05-13 | ELOX | N/A | Pontifax Management 4 G.P. (2015) Ltd. | 10% owner | Other | BUY | $1.35 | 5,925,925 | $7,999,999 | 616,592 | +100.0% |
| 2021-05-17 14:02 | 2021-05-13 | ELOX | N/A | Nussbaum Ran | Director | Other | BUY | $1.35 | 5,925,925 | $7,999,999 | 616,592 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.